Eris Lifesciences Limited · NSE: ERIS · BSE: 540596
Eris Lifesciences
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 29 Jul 2026.
Q1 FY27 · Consolidated
Revenue
873.25₹ Cr
+13.0% vs year ago
Net profit
143.32₹ Cr
+14.6% vs year ago
EPS, basic
10.28₹
+18.7% vs year ago
Net margin
16.4%
+0.2 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 873.25 | +13.0% | 143.32 | +14.6% | 10.28 | 29 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 756.56 | +7.3% | 279.10 | +172.7% | 20.60 | 20 May 2026 |
| Q3 FY26Oct–Dec 2025 | 807.45 | +11.0% | 108.83 | +25.2% | 7.32 | 13 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 792.41 | +7.2% | 134.47 | +39.6% | 8.82 | 12 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 773.00 | +7.4% | 125.10 | +39.9% | 8.66 | 05 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 705.30 | +28.0% | 102.35 | +28.5% | 6.90 | 19 May 2025 |
| Q3 FY25Oct–Dec 2024 | 727.45 | +49.6% | 86.93 | −14.3% | 6.15 | 05 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 738.95 | +46.2% | 96.35 | −21.2% | 6.73 | 28 Oct 2024 |
| Q1 FY25Apr–Jun 2024 | 719.72 | +54.2% | 89.42 | −4.5% | 6.11 | 05 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 550.92 | +36.8% | 79.63 | +29.5% | 5.22 | 23 May 2024 |
| Q3 FY24Oct–Dec 2023 | 486.30 | +14.9% | 101.46 | +1.2% | 7.55 | 15 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 505.30 | +9.7% | 122.31 | +2.5% | 9.08 | 13 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 466.62 | +17.1% | 93.65 | +0.6% | 6.97 | 07 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 402.80 | +31.7% | 61.48 | −23.1% | 4.81 | 26 May 2023 |
| Q3 FY23Oct–Dec 2022 | 423.26 | — | 100.23 | — | 7.49 | 18 Jan 2023 |
| Q2 FY23Jul–Sep 2022 | 460.51 | +28.0% | 119.38 | +0.8% | 8.84 | 20 Oct 2022 |
| Q1 FY23Apr–Jun 2022 | 398.58 | +14.1% | 93.08 | −12.7% | 6.96 | 08 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 305.95 | +10.0% | 79.97 | +17.2% | 5.91 | 04 May 2022 |
| Q2 FY22Jul–Sep 2021 | 359.67 | +9.0% | 118.39 | +9.9% | 8.71 | 30 Oct 2021 |
| Q1 FY22Apr–Jun 2021 | 349.27 | +19.1% | 106.66 | +19.8% | 7.86 | 29 Jul 2021 |
| Q4 FY21Jan–Mar 2021 | 278.21 | +11.9% | 68.25 | +21.3% | 5.03 | 14 May 2021 |
| Q3 FY21Oct–Dec 2020 | 310.42 | +16.5% | 90.15 | +42.0% | 6.64 | 28 Jan 2021 |
| Q2 FY21Jul–Sep 2020 | 329.99 | +15.9% | 107.72 | +16.2% | 7.93 | 05 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 293.24 | +6.9% | 89.02 | +5.9% | 6.56 | 04 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 248.57 | +15.7% | 56.27 | +4.4% | 4.13 | 27 Jun 2020 |
| Q3 FY20Oct–Dec 2019 | 266.40 | +5.5% | 63.47 | −20.9% | 4.62 | 15 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 284.79 | +7.8% | 92.71 | +8.4% | 6.74 | 07 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 274.30 | +9.4% | 84.06 | +17.5% | 6.11 | 27 Jul 2019 |
| Q4 FY19Jan–Mar 2019 | 214.82 | — | 53.88 | — | 3.93 | 22 May 2019 |
| Q3 FY19Oct–Dec 2018 | 252.40 | — | 80.20 | — | 5.83 | 30 Jan 2019 |
| Q2 FY19Jul–Sep 2018 | 264.18 | — | 85.51 | — | 6.20 | 06 Nov 2018 |
| Q1 FY19Apr–Jun 2018 | 250.76 | — | 71.56 | — | 5.18 | 10 Aug 2018 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 443.99 | −23.3% | 48.30 | −51.7% | 3.49 | 29 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 277.31 | −31.5% | (8.60) | Turned loss | (0.63) | 20 May 2026 |
| Q3 FY26Oct–Dec 2025 | 315.29 | −21.1% | 3.09 | +73.6% | 0.23 | 13 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 650.50 | +51.7% | 149.57 | +432.3% | 10.98 | 12 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 578.64 | +26.7% | 99.99 | +486.8% | 7.34 | 05 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 404.77 | +18.6% | 30.47 | −22.9% | 2.24 | 19 May 2025 |
| Q3 FY25Oct–Dec 2024 | 399.73 | +23.2% | 1.78 | −94.4% | 0.13 | 05 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 428.75 | +4.6% | 28.10 | −76.1% | 2.06 | 28 Oct 2024 |
| Q1 FY25Apr–Jun 2024 | 456.69 | +11.0% | 17.04 | −84.6% | 1.25 | 05 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 341.30 | +8.5% | 39.51 | −55.0% | 2.90 | 23 May 2024 |
| Q3 FY24Oct–Dec 2023 | 324.41 | −2.3% | 31.66 | −68.1% | 2.33 | 15 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 409.71 | +15.3% | 117.81 | +2.3% | 8.66 | 13 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 411.29 | +25.1% | 110.74 | +15.8% | 8.14 | 07 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 314.58 | +11.5% | 87.84 | +1.3% | 6.46 | 26 May 2023 |
| Q3 FY23Oct–Dec 2022 | 332.01 | +9.0% | 99.38 | −4.5% | 7.31 | 18 Jan 2023 |
| Q2 FY23Jul–Sep 2022 | 355.37 | +10.1% | 115.20 | −3.8% | 8.47 | 20 Oct 2022 |
| Q1 FY23Apr–Jun 2022 | 328.76 | +7.3% | 95.59 | −10.4% | 7.03 | 08 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 282.14 | +9.8% | 86.71 | +25.0% | 6.38 | 04 May 2022 |
| Q3 FY22Oct–Dec 2021 | 304.63 | +6.1% | 104.06 | +17.4% | 7.66 | 28 Jan 2022 |
| Q2 FY22Jul–Sep 2021 | 322.66 | +6.4% | 119.71 | +13.5% | 8.81 | 30 Oct 2021 |
| Q1 FY22Apr–Jun 2021 | 306.30 | +17.1% | 106.72 | +22.5% | 7.86 | 29 Jul 2021 |
| Q4 FY21Jan–Mar 2021 | 256.85 | +11.3% | 69.35 | +25.8% | 5.11 | 14 May 2021 |
| Q3 FY21Oct–Dec 2020 | 287.13 | +12.9% | 88.63 | +41.4% | 6.52 | 28 Jan 2021 |
| Q2 FY21Jul–Sep 2020 | 303.37 | +11.2% | 105.49 | +15.3% | 7.77 | 05 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 261.48 | −0.3% | 87.13 | +6.3% | 6.42 | 04 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 230.74 | +16.3% | 55.11 | +5.1% | 4.05 | 27 Jun 2020 |
| Q3 FY20Oct–Dec 2019 | 254.27 | +10.2% | 62.68 | −20.5% | 4.55 | 15 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 272.90 | +13.3% | 91.53 | +9.0% | 6.66 | 07 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 262.33 | +15.8% | 81.96 | +16.9% | 5.96 | 27 Jul 2019 |
| Q4 FY19Jan–Mar 2019 | 198.43 | — | 52.42 | — | 3.81 | 22 May 2019 |
| Q3 FY19Oct–Dec 2018 | 230.80 | — | 78.88 | — | 5.74 | 30 Jan 2019 |
| Q2 FY19Jul–Sep 2018 | 240.81 | — | 83.98 | — | 6.10 | 06 Nov 2018 |
| Q1 FY19Apr–Jun 2018 | 226.50 | — | 70.10 | — | 5.10 | 10 Aug 2018 |
65 filings on record for this company.